Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. More Details
Average dividend payer with mediocre balance sheet.
Share Price & News
How has Patterson Companies's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PDCO has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: PDCO exceeded the US Healthcare industry which returned 22.1% over the past year.
Return vs Market: PDCO exceeded the US Market which returned 19.5% over the past year.
Price Volatility Vs. Market
How volatile is Patterson Companies's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StDoes Patterson Companies (NASDAQ:PDCO) Have A Healthy Balance Sheet?
2 months ago | Simply Wall StPatterson Companies, Inc. (NASDAQ:PDCO) Investors Should Think About This Before Buying It For Its Dividend
3 months ago | Simply Wall StPatterson Companies (NASDAQ:PDCO) Share Prices Have Dropped 53% In The Last Five Years
Is Patterson Companies undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: PDCO ($26.6) is trading above our estimate of fair value ($26.4)
Significantly Below Fair Value: PDCO is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: PDCO is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: PDCO is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PDCO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PDCO is good value based on its PB Ratio (3x) compared to the US Healthcare industry average (3.1x).
How is Patterson Companies forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PDCO is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: PDCO is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PDCO's is expected to become profitable in the next 3 years.
Revenue vs Market: PDCO's revenue (3.3% per year) is forecast to grow slower than the US market (10% per year).
High Growth Revenue: PDCO's revenue (3.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PDCO's Return on Equity is forecast to be low in 3 years time (11%).
How has Patterson Companies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PDCO is currently unprofitable.
Growing Profit Margin: PDCO is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PDCO is unprofitable, and losses have increased over the past 5 years at a rate of 47.5% per year.
Accelerating Growth: Unable to compare PDCO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PDCO is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (28%).
Return on Equity
High ROE: PDCO has a negative Return on Equity (-69.61%), as it is currently unprofitable.
How is Patterson Companies's financial position?
Financial Position Analysis
Short Term Liabilities: PDCO's short term assets ($1.5B) exceed its short term liabilities ($978.8M).
Long Term Liabilities: PDCO's short term assets ($1.5B) exceed its long term liabilities ($812.7M).
Debt to Equity History and Analysis
Debt Level: PDCO's debt to equity ratio (86.8%) is considered high.
Reducing Debt: PDCO's debt to equity ratio has reduced from 110.6% to 86.8% over the past 5 years.
Debt Coverage: PDCO's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: PDCO is unprofitable, therefore interest payments are not well covered by earnings.
What is Patterson Companies's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PDCO's dividend (3.91%) is higher than the bottom 25% of dividend payers in the US market (1.62%).
High Dividend: PDCO's dividend (3.91%) is low compared to the top 25% of dividend payers in the US market (4.66%).
Stability and Growth of Payments
Stable Dividend: PDCO's dividends per share have been stable in the past 10 years.
Growing Dividend: PDCO's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: PDCO is paying a dividend but the company is unprofitable.
Future Payout to Shareholders
Future Dividend Coverage: PDCO's dividends in 3 years are forecast to be covered by earnings (57.3% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mark Walchirk (54 yo)
Mr. Mark S. Walchirk has been the Chief Executive Officer and President of Patterson Companies, Inc. since November 20, 2017. Mr. Walchirk served as the President of U.S. Pharmaceutical at McKesson Corpora ...
CEO Compensation Analysis
Compensation vs Market: Mark's total compensation ($USD5.86M) is about average for companies of similar size in the US market ($USD5.61M).
Compensation vs Earnings: Mark's compensation has increased whilst the company is unprofitable.
|CEO, President & Director||2.92yrs||US$5.86m||0.065% |
|CFO & Treasurer||2.33yrs||US$2.32m||0.028% |
|VP, General Counsel & Secretary||5.25yrs||US$1.26m||0.039% |
|Chief Human Resources Officer||2.42yrs||US$1.18m||0.0017% |
|President of the Dental Business Unit||1.75yrs||US$1.29m||0.00089% |
|Chief Information Officer||3.92yrs||no data||no data|
|Vice President of Investor Relations||4.92yrs||no data||no data|
|Chief Compliance Officer||0.58yr||no data||no data|
|Chief Innovation Officer||4.33yrs||US$970.71k||no data|
|President of Animal Health International||3.25yrs||US$2.14m||0.042% |
|Corporate Controller||2.33yrs||US$476.40k||0.011% |
|Chief Commercial Officer of Patterson Veterinary Supply||no data||US$1.50m||no data|
Experienced Management: PDCO's management team is considered experienced (2.9 years average tenure).
|CEO, President & Director||2.92yrs||US$5.86m||0.065% |
|Independent Director||16.83yrs||US$231.00k||0.064% |
|Independent Director||9.08yrs||US$242.88k||0.034% |
|Independent Non-Executive Chairman of the Board||3.33yrs||US$326.00k||0.074% |
|Independent Director||2.33yrs||US$272.25k||0.016% |
|Independent Director||6.58yrs||US$234.75k||0.027% |
|Independent Director||2.58yrs||US$281.00k||0.016% |
|Independent Director||3.42yrs||US$277.25k||0.020% |
Experienced Board: PDCO's board of directors are considered experienced (3.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Patterson Companies, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Patterson Companies, Inc.
- Ticker: PDCO
- Exchange: NasdaqGS
- Founded: 1877
- Industry: Health Care Distributors
- Sector: Healthcare
- Market Cap: US$2.532b
- Shares outstanding: 95.19m
- Website: https://www.pattersoncompanies.com
Number of Employees
- Patterson Companies, Inc.
- 1031 Mendota Heights Road
- Saint Paul
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PDCO||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||Oct 1992|
|PD2||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Oct 1992|
|0KGB||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Oct 1992|
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through three segments; Dental, Animal Health, and Corpor ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/10/20 00:02|
|End of Day Share Price||2020/10/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.